Milan, MI, United States of America

Tarek Hamouda

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 435(Granted Patents)


Location History:

  • Ypsilanti, MI (US) (2000 - 2010)
  • Ann Arbor, MI (US) (2015)
  • Milan, MI (US) (2003 - 2021)
  • St. Louis, MO (US) (2023)

Company Filing History:


Years Active: 2000-2023

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Innovations and Patents of Tarek Hamouda: A Leader in Nanoemulsion Technology

Introduction: Tarek Hamouda is a prominent inventor based in Milan, MI (US), recognized for his significant contributions to the fields of immunology and nanoemulsion technology. With a remarkable portfolio of 22 patents, he has developed innovative approaches that enhance immune responses, particularly in the context of vaccine development.

Latest Patents: Among Tarek's latest patents are two noteworthy inventions that demonstrate his expertise in immune response technologies. The first patent focuses on "Nanoemulsion and methods of use thereof," detailing compositions and methods designed to induce an immune response in subjects. This innovation not only outlines the methods for screening immune responses but also offers valuable contributions to the field of immunology. The second patent, titled "Herpes simplex virus nanoemulsion vaccine," relates to the development of a subunit vaccine composition. This advanced vaccine integrates isolated surface glycoproteins and fusion proteins from herpes simplex viruses with a nanoemulsion, enhancing immune response and effectiveness.

Career Highlights: Tarek Hamouda has made significant strides in his career, working with prestigious organizations such as the University of Michigan and Nanobio Corporation. His experience in these institutions has allowed him to push the boundaries of scientific research and innovation in immunology.

Collaborations: Throughout his career, Tarek has collaborated with notable professionals in the field, including James R Baker, Jr. and Amy Shih. These partnerships have fostered an environment of creativity and collaboration, resulting in groundbreaking advancements in vaccine technology and immune response.

Conclusion: Tarek Hamouda's contributions to nanoemulsion technology and immunology are invaluable. His extensive patent portfolio and collaborative efforts highlight his dedication to innovation and the advancement of public health solutions. As he continues to explore and develop new technologies, Tarek remains a significant figure in the evolution of modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…